Authors
Loading...
Cross-sectional survey revealed 46.4% MCV2 coverage in Cameroon, indicating barriers to vaccination uptake.
Nloga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: